APP and Alzheimer disease: The discovery that multiple eiscosanoids could increase APP expression through interaction with neuronal receptors suggested that a vicious cycle may ensue in the AD brain, whereby initial glial activation by Aβ oligomers and/or plaques results in a release of inflammatory eicsosanoids that subsequently up-regulate APP and Aβ production.